Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
984.8 DKK | -0.22% | +6.70% | -25.95% |
27/03 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04/03 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-25.95% | 49.81L | |
+15.19% | 12TCr | |
+19.91% | 11TCr | |
+8.24% | 2.36TCr | |
-19.80% | 2.04TCr | |
-16.19% | 1.65TCr | |
-13.45% | 1.64TCr | |
-44.35% | 1.56TCr | |
+66.67% | 1.52TCr | |
+2.13% | 1.35TCr |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Orphazyme CFO Anders Vadsholt Takes on CEO Role a Month Early